The Pharmalot blog reports today on a Reuter's story about an oral vaccine for Alzheimer's that proved successful at diminishing signs of Alzheimer's in a study of 28 mice bred to develop the disease. Limited testing of the vaccine in humans may be next.
The vaccine works by reducing the amount of amyloid plaques in the brains of the diseased mice, visibly improving their cognitive function. "In other words," writes Ed Silverman at Pharmalot, "[the mice] could find their way to the kitchen counter again."
- Log in to post comments